Literature DB >> 7576721

Synergistic interaction between ORM1 and C3 types in disease associations.

C Fan1, P O Nylander, U Stendahl, M Thunell, L Beckman.   

Abstract

In previous studies of orosomucoid (ORM) types and disease the ORM1 1 type has been found to be associated with sarcoidosis and other immunogenetic diseases, and the ORM 1 2 type with different types of carcinomas. We report significant associations between ORM1 and C3 types in sarcoidosis and breast cancer, but not in healthy individuals. The ORM1 1 and C3S variants in combination increased the risk of sarcoidosis, and the ORM1 2 and C3F variants together gave an increased risk of breast cancer. A probable mechanism may be that the ORM1 and C3 molecules modify the immune response by interacting with the lymphoid cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576721

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  1 in total

1.  Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Authors:  Tao Fang; Meiling Cui; Ji Sun; Chao Ge; Fangyu Zhao; Lin Zhang; Hua Tian; Lixing Zhang; Taoyang Chen; Guoping Jiang; Haiyang Xie; Ying Cui; Ming Yao; Hong Li; Jinjun Li
Journal:  Oncotarget       Date:  2015-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.